A Budapest-based biotech startup
ELISA Protocol for COVID-19 IgG Antibody Detection
ZTA Biotech is the Intellectual Rights holder of the protocol and is represented by a Hungarian scientist. The formula was developed by an international team of researchers including a Canadian, an Israeli, and a Dutch scholar. The main research direction is achieved by an in-house developed, highly specialized software package for simulation and modeling of critical protein-protein interactions. The results based on the prediction of the algorithm are analyzed and translated into commercial products. For more information, contact us at email@example.com. You can also call ZTA Biotech at +1-512-234-3335 in the United States or +36 30 508 6127 in Europe.